Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders

Driban, M; Kedia, N; Arora, S; Chhablani, J

Chhablani, J (通讯作者),Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15260 USA.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2023; 16 (11): 1125

Abstract

IntroductionRetinal vein occlusion (RVO) is the second leading cause of blindness from retinal vascular disease behind diabetic retinopathy. Anti-vasc......

Full Text Link